Effectiveness of Cetuximab in Combination with Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A 1:2 Propensity Score-matched Analysis.

J Cancer · 2018 · PMC5950594 · PMID 29760803

Europe PMC DOI

hedged sentence

0.3010

closest p · 6.0× alpha

0.3010

boldest claim

The sentences

a marginal trendP = 0.301not close (p > 0.1)

Furthermore, a marginal trend of increasing risk of 3-year DMFS rates (83.9% vs 78.4%, P = 0.301) and 3-year OS rates (91.2% vs 85.8%, P = 0.123) was found (Figure 1 ).

also in 626 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.